AnthonyRFrenchMD

PubMed

• MicroRNA-146a deficiency enhances host protection against murine cytomegalovirus.
  Pamela Wong, Jeffrey W Leong, Hyogon Sohn, Lily Chang, Catherine R Keppel
  European Journal of Immunology. 2024-12-01
• Immunology of Cytokine Storm Syndromes: Natural Killer Cells.
  Anthony R French, Randy Q Cron, Megan A Cooper
  Advances in Experimental Medicine and Biology. 2024-01-01
• 1 citations
  Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency.
  Joshua B Alinger, Emily M Mace, Justin R Porter, Annelise Y Mah-Som, Allyssa L Daugherty
  The Journal of Allergy and Clinical Immunology. 2024-01-01

Journal Articles

• Mesenteric vasculitis in children with systemic lupus erythematosus  
  Fotis L, Baszis KW, French AR, Cooper MA, White AJ, Clin Rheumatol, 1/1/2016
• Elevated double negative T cells in pediatric autoimmunity  
  Tarbox JA, Keppel MP, Topcagic N, Mackin C, Ben Abdalla M, Baszis KW, White AJ, French AR, Cooper MA, Journal of Clinical Immunology, 1/1/2014
• Murine Cytomegalovirus protein pM92 is a conserved beta-herpesvirus regulator of late gene expression  
  Chapa TJ, Perng YC, French AR, Yu, D, J Virol, 1/1/2014
• Natural killer cells in human autoimmune disorders  
  Fogel LA, Yokoyama WM, French AR, Arthritis Res Ther, 1/1/2013
• miR-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways  
  Sullivan RP, Fogel LA, Leong JW, Schneider SE, Wong R, Romee R, Thai T, Sexl V, Matkovich SJ, Dorn GW, French AR, Fehniger TA, J Immunol, 1/1/2013
• Hypogammaglobulinemia in pediatric systemic lupus erythematosus  
  Lim E, Tao Y, White AJ, French AR, Cooper MA, Lupus, 1/1/2013
• Mechanistic model of natural killer cell proliferative response to IL-15 receptor stimulation  
  Zhao YM, French AR, PLOS Comput Biol, 1/1/2013
• Markers of nonselective and specific NK cell activation  
  Fogel LA, Sun MM, Geurs TL, Carayannopoulous LN, French AR, J Immunol, 1/1/2013
• Inositol tetrakisphosphate limits NK cell effector functions by controlling phosphoinositide 3-kinase signaling  
  Sauer K, Park E, Siegemund S, French AR, Wahle JA, Sternberg L, Jonsson AH, Yokoyama WM, Huang YH, Blood, 1/1/2013
• Activation mechanisms of natural killer cell during Influenza virus infection  
  Hwang I, Kakarla T, Duriancik DM, Choi S, Cho C, Lee T, Park H, Scott JM, Jo M, Ortiz T, French AR, Beli E, Gardner E, Kim S, PLoS One, 1/1/2012
• The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia  
  Mon T, L’Ecuyer S, Farber NB, White AJ, Baszis KW, Hearn JK, Spiegel TE, French AR, Kitcharoensakkul M, Lupus, 1/1/2012
• Two-compartment model of natural killer cell proliferation: insight from population response to IL-15 stimulation  
  Zhao YM, French AR, J Immunol, 1/1/2012
• MicroRNA deficient NK cells exhibit decreased survival but enhanced function  
  Sullivan RP, Leong JW, Schneider SE, Keppel CR, Germino E, French AR, Fehniger TA, J Immunol, 1/1/2012
• Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during MCMV infection  
  Geurs TL, Zhao YM, Hill EB, French AR, J Immunol, 1/1/2009
• HLA alleles determine differences in human natural killer cell responsiveness and potency  
  Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, Mohanakumar T, Hsu KC, Dupont B, Yokoyama WM, Proc Natl Acad Sci USA, 1/1/2008
• Chronic lymphocytosis of functionally immature NK cells  
  French AR, Kim S, Fehniger TA, Pratt JR, Yang L, Song YJ, Caliguri MA, Yokoyama WM, J Allergy Clin Immunol, 1/1/2007
• Rituximab for the treatment of juvenile dermatomyositis: A case series of four pediatric patients  
  Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ, Arthritis Rheum, 1/1/2007
• Histoplasmosis in a child with JRA on low-dose methotrexate  
  Hunstad DA, French AR, Rheumatology, 1/1/2007
• DAP12 signaling directly augments pro-proliferative cytokine stimulation of natural killer cells during viral infection  
  French AR, Sjolin H, Kim S, Koka R, Yang L, Young DA, Cerboni C, Tomasello E, Ma A, Vivier E, Karre K, Yokoyama WM, J Immunol, 1/1/2006
• Licensing of natural killer cells by host MHC class I  
  Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM, Nature, 1/1/2005
• A lymphotoxin-interferon a axis essential for lymphocyte survival revealed during cytomegalovirus infection  
  Banks TA, Rickert S, Benedict CA, Ma L, Ko M, Meier J, Ha W, Granger SW, Turovskaya O, Elewaut D, Otero D, French AR, Henry SC, Hamilton JD, Scheu S, Pfeffer K, Ware CF, J Immunol, 1/1/2005
• Coordinate expression of type-1 cytokines by natural killer cells during MCMV infection  
  Dorner BG, Smith HRC, French AR, Kim S, Poursine-Laurent J, Beckman DL, Pingel JT, Kroczek RA, Yokoyama WM, J Immunol, 1/1/2004
• TLR9-dependent recognition of murine cytomegalovirus (MCMV) by interferon-producing cell and dendritic cells generates a coordinated cytokine response that activates a...  
  Krug A, French AR, Barchet W, Fischer J, Dzionek A, Pingel JT, Akira S, Yokoyama WM, Colonna M, Immunity, 1/1/2004
• Osteopenia in adults with a history of juvenile rheumatoid arthritis  
  French AR, Mason T, Nelson AM, Crowson CS, OFallon WM, Khosla S, Gabriel SE, J Rheum, 1/1/2002
• Increased mortality in adults with a history of juvenile rheumatoid arthritis  
  French AR, Mason T, Nelson AM, O'Fallon WM, Gabriel SE, Arthritis Rheum, 1/1/2001
• Join now to see all